NasdaqCM - Delayed Quote USD
Singular Genomics Systems, Inc. (OMIC)
At close: November 22 at 4:00 PM EST
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | -- | 1 | 1 |
| Avg. Estimate | -7.85 | 0 | -34.45 | -31.28 |
| Low Estimate | -7.85 | 0 | -34.45 | -31.28 |
| High Estimate | -7.85 | 0 | -34.45 | -31.28 |
| Year Ago EPS | -9.3 | -- | -39 | -34.45 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 3 |
| Avg. Estimate | 1.77M | 1.82M | 3.35M | 10.15M |
| Low Estimate | 1.77M | 1.82M | 3.35M | 5.1M |
| High Estimate | 1.77M | 1.82M | 3.35M | 15.19M |
| Year Ago Sales | 1.08M | 442k | 2.91M | 3.35M |
| Sales Growth (year/est) | 63.64% | 311.54% | 15.22% | 202.66% |
Earnings History
| CURRENCY IN USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -9.8 | -9.6 | -8.95 | -7.86 |
| EPS Actual | -9.3 | -10.2 | -8.57 | -6.72 |
| Difference | 0.5 | -0.6 | 0.38 | 1.14 |
| Surprise % | 5.12% | -6.25% | 4.25% | 14.50% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -7.85 | 0 | -34.45 | -31.28 |
| 7 Days Ago | 0 | 0 | -34.45 | -31.28 |
| 30 Days Ago | 0 | 0 | -4.31 | -31.95 |
| 60 Days Ago | -8.1 | 0 | -35.1 | -35.4 |
| 90 Days Ago | -8.1 | 0 | -35.1 | -35.4 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 1 |
| Up Last 30 Days | -- | -- | -- | 1 |
| Down Last 7 Days | 1 | -- | 1 | -- |
| Down Last 30 Days | 1 | -- | 1 | -- |
Growth Estimates
| CURRENCY IN USD | OMIC | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 15.59% | -- | -- | 5.00% |
| Next Qtr. | -- | -- | -- | 12.00% |
| Current Year | 11.67% | -- | -- | 2.10% |
| Next Year | 9.20% | -- | -- | 12.20% |
Upgrades & Downgrades
| Maintains | Goldman Sachs: Neutral to Neutral | 7/9/2024 |
| Maintains | Goldman Sachs: Neutral to Neutral | 5/15/2024 |
| Maintains | UBS: Neutral to Neutral | 3/20/2024 |
| Maintains | Goldman Sachs: Neutral to Neutral | 1/23/2024 |
| Maintains | Goldman Sachs: Neutral to Neutral | 1/22/2024 |
| Maintains | Goldman Sachs: Neutral to Neutral | 8/10/2023 |
Related Tickers
AKYA Akoya Biosciences, Inc.
2.1100
-0.47%
OWX.MU Ypsomed Holding AG
118.60
0.00%
KRMD KORU Medical Systems, Inc.
3.5200
-1.68%
PQX1.F Biotage AB (publ)
13.00
+4.33%
PBHDF Paramount Bed Holdings Co., Ltd.
19.74
0.00%
PDEX Pro-Dex, Inc.
46.75
+10.44%
BVC.L BATM Advanced Communications Ltd.
19.35
-0.51%
WHSI Wearable Health Solutions, Inc.
0.0001
0.00%
AMS.L Advanced Medical Solutions Group plc
209.50
+2.44%
BIOT.ST Biotage AB (publ)
155.00
+2.58%